Buffett's Verdict on Your ETF Soup: Why Less Is Often More

Well, pull up a chair. Looking at your data, this portfolio is fresh out of the oven. At zero months old, you're up about 1.5%, but honestly, trying to judge an investing track record after a few days is like calling a baseball game after the first pitch. I'm not going to grade your returns because you simply don't have a track record yet.

Instead, we are going to look under the hood at the engine you just built. Charlie Munger and I always said that if you buy good businesses and hold them, the scoreboard takes care of itself. You've got a mix of sensible broad-market ideas and a few head-scratchers. Let's see if this engine is built for a cross-country road trip or if it's going to rattle itself apart on the first pothole.

You've taken my advice to heart for the most part: nearly 70% of your money is parked in broad market ETFs. If you don't have the time to read annual reports and value individual businesses, buying the index is the smartest thing you can do. You've got 56% of your money tied to North America and roughly 39% in global exposure. That is a perfectly sensible way to capture the long-term growth of human enterprise.

When you do pick individual stocks, you've grabbed a couple of beauties. Visa at 4.5% is a classic toll-bridge business with a massive network effect. S&P Global at 2.7% is the textbook definition of an intangible asset moat. They sit right in the middle of the financial highway and collect a fee every time a car drives by. We own plenty of Visa at Berkshire for exactly that reason.

But I have to talk about your wallet. Your cash reserves sit at a microscopic 0.49%. I still live in the same modest house in Omaha I bought in 1958, and I like to keep things simple, but I never walk around with empty pockets. Cash is a call option with no expiration date. With 10-year Treasury yields sitting pretty around 4.65% right now, holding cash isn't the penalty it used to be. By holding virtually zero, you have absolutely no dry powder for when Mr. Market gets depressed and puts wonderful businesses on sale.

There is a fine line between a diversified portfolio and a confused one, and you are tripping right over it.

🚩 ETF Alphabet Soup: You own EQQQ (18.3%), VUSA (11.2%), VWRL (9.6%), HWWA (7.7%), WINC (7.7%), VHYL (5.1%), IUKD (5%), and LDGG (4.9%). You are buying the entire haystack, and then you are buying six different handfuls of hay from the exact same pile. You are paying multiple expense ratios to own the same big tech companies over and over again. Diversification is protection against ignorance, but you are just duplicating your own work.

🚩 The Biotech Lottery Ticket: Your second-largest individual stock is Tarsus Pharmaceuticals at 5.1%. Now, I don't know the first thing about developing molecules, and unless you are a biochemist, neither do you. Biotech is a brutal game of clinical trials and FDA approvals. It is pure speculation. Betting 5% of your money on a pipeline you can't control is a gamble, not an investment.

🚩 Empty Ammo Belt: I will say it again because it matters: a 0.49% cash balance means your hands are tied. If the S&P drops 20% tomorrow because of trouble in the Middle East or rate jitters, you can only sit there and watch. You want the flexibility to swing when a fat pitch comes across the plate.

Since we can't judge your performance yet, I am grading your structure. I'll give this a 6.5 out of 10. The foundation is solid, but the house on top has too many weirdly shaped rooms. You have the right idea with broad market funds and moat-heavy financial picks, but you've overcomplicated the execution.

Here is what you should do next:

1. Clean up the ETF mess. Pick one global fund and one US fund. Sell the overlapping dividend and multi-factor funds that just clutter your statements and drain your returns with fees.

2. Build a cash pile. Let some dividends pile up or trim your redundant positions until you have at least 5% to 10% in cash. You need dry powder.

3. Question your speculative bets. Look hard at Tarsus Pharmaceuticals. If you wouldn't buy the whole company today, you shouldn't own a piece of it.

Remember, the stock market is a device for transferring money from the impatient to the patient. Clean up this portfolio, build some reserves, and then sit on your hands.